Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.08.2022 | Case report

Risperidone

Hyperprolactinaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Altun IK, et al. Decrease in Prolactin Levels after Switching from Long-Acting Injectable Risperidone to Paliperidone Palmitate: A Case Report?. Psychiatry and Clinical Psychopharmacology 27 (Suppl. 1): 134 abstr. 0217, May 2017. Available from: URL: http://doi.org/10.1080/24750573.2017.1308709 [abstract] Altun IK, et al. Decrease in Prolactin Levels after Switching from Long-Acting Injectable Risperidone to Paliperidone Palmitate: A Case Report?. Psychiatry and Clinical Psychopharmacology 27 (Suppl. 1): 134 abstr. 0217, May 2017. Available from: URL: http://​doi.​org/​10.​1080/​24750573.​2017.​1308709 [abstract]
Metadaten
Titel
Risperidone
Hyperprolactinaemia: case report
Publikationsdatum
01.08.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-21471-4

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Etonogestrel